H. Morrisson, Contributions to the microscopic anatomy of the pancreas by Paul Langerhans, Bull Inst Hist Med, vol.5, pp.259-297, 1937.

F. Brunicardi, J. Stagner, and S. Bonner-weir, Microcirculation of the Islets of Langerhans: Long Beach Veterans Administration Regional Medical Education Center Symposium, Diabetes, vol.45, issue.4, pp.385-392, 1996.
DOI : 10.2337/diab.45.4.385

M. Brissova and A. Powers, Revascularization of Transplanted Islets: Can It Be Improved?, Diabetes, vol.57, issue.9, pp.2269-71, 2008.
DOI : 10.2337/db08-0814

E. Lammert, G. Gu, and M. Mclaughlin, Role of VEGF-A in Vascularization of Pancreatic Islets, Current Biology, vol.13, issue.12, pp.1070-1074, 2003.
DOI : 10.1016/S0960-9822(03)00378-6

P. Gilon and J. Henquin, Mechanisms and physiological significance of the cholinergie control of pancreatic ~-cell function, Endocr Rev, vol.22, pp.565-604, 2001.

. Il, A. Hoorens, M. Van-de-castele, and G. Kloppel, Glucose promotes survival of rat pancreatic beat cells by activing synthesis of proteins which suppress a constitutive apoptotic program, J Clin Invest, vol.98, pp.1568-1574, 1996.

I. Swenne, Pancreatic Beta-cell growth and diabetes mellitus, Diabetologia, vol.33, issue.Suppl 2, pp.193-213, 1992.
DOI : 10.1111/j.1600-0773.1983.tb03440.x

S. Bonner-weir, Life and death of the pancreatic ~-cells, Trends Endocrinol Metab, vol.Il, pp.375-378, 2000.

J. Palmer, C peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, Diabetes, vol.53, pp.21-22260, 2001.

J. Wahren, B. Johansson, and . Wallberg-henriksson, Does C-peptide have a physiological role?, Diabetologia, vol.130, issue.Suppl 1, pp.99-107, 1994.
DOI : 10.1007/BF00400832

M. Cotter, K. Ekberg, and J. Wahren, Effects of Proinsulin C-Peptide in Experimental Diabetic Neuropathy: Vascular Actions and Modulation by Nitric Oxide Synthase Inhibition, Diabetes, vol.52, issue.7, pp.1812-1817, 2003.
DOI : 10.2337/diabetes.52.7.1812

B. Johansson, K. Borg, and E. Ferngvist-forbes, Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus, Diabetic Medicine, vol.303, issue.3, pp.181-189, 2000.
DOI : 10.1136/bmj.303.6794.81

J. Palmer, C-peptide in the natural history of type 1 diabetes, Diabetes/Metabolism Research and Reviews, vol.201, issue.4, pp.325-328, 2009.
DOI : 10.1152/ajpendo.00001.2003

D. The and . Group, Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes control and Complications trial (DCCT), J Clin Endocrinol Metab, vol.65, pp.30-36, 1987.

. Sosenko-lm and L. Palmer-lp,-rafkin-mervis, Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1, Diabetes Care, vol.31, issue.11, pp.2188-2192, 2008.
DOI : 10.2337/dc08-0935

D. The and . Group, Effects of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized controlled trial, Ann Intern Med, vol.128, issue.7, pp.517-523, 1998.

A. Hansen, C-Peptide Exerts Beneficial Effects on Myocardial Blood Flow and Function in Patients With Type 1 Diabetes, Diabetes, vol.51, issue.10, pp.3077-3082, 2002.
DOI : 10.2337/diabetes.51.10.3077

E. Hedon, Sur la consommation du sucre chez le chien après l'extirpation du pancréas, Arch Physiol Norm Pathol, vol.5, pp.154-163, 1893.

R. Lillehei, R. Simmons, . Najarian-ls, and R. Weil, Pancreatico-duodenal allotransplantation: Experimental and clinical experience, Acta Diabetologica Latina, vol.17, issue.1, pp.405-441, 1970.
DOI : 10.1007/BF01556827

. Dubernard-lm, . Traeger-l, and P. Neyra, A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man, Surgery, vol.84, pp.633-642, 1978.

A. Farney, E. Cho, and E. Schweitzer, Simultaneous Cadaver Pancreas Living-Donor Kidney Transplantation: A New Approach for the Type 1 Diabetic Uremic Patient, Annals of Surgery, vol.232, issue.5, pp.696-699, 2000.
DOI : 10.1097/00000658-200011000-00012

R. Gruessner, D. Sutherland, and M. Drangstveit, SIMULTANEOUS KIDNEY AND SEGMENTAL PANCREAS TRANSPLANTS FROM LIVING RELATED DONORS-THE FIRST TWO SUCCESSFUL CASES, Transplantation, vol.61, issue.8, pp.1265-68, 1996.
DOI : 10.1097/00007890-199604270-00025

S. Withe, J. Shaw, and D. Sutherland, Pancreas transplantation, Lancet, vol.373, pp.1808-1825, 2009.

A. Gruessner, D. Sutherland, and D. Dulli, Pancreas after kidney transplants in posturemic patients with type 1 diabetes mellitus, J Am Soc Nephrol, vol.12, pp.2490-99, 2001.

X. Martin, P. Petruzzo, and M. Dawalu-'a, Effects of portal versus systemic venous drainage in kidney-pancreas recipients, Transplant International, vol.12, issue.1, pp.64-68, 2000.
DOI : 10.1016/S0041-1345(97)01258-X

J. Paineau, C. D. Couderc, and J. , Expérience chirurgicale lors de 50 transplantations de pancréas segmentaire injecté de Néoprène* : Technique et complications post-opératoires, J Chir (Paris), vol.128, pp.275-80, 1991.

U. Boggi, F. Vistoli, and S. Signori, A Technique for Retroperitoneal Pancreas Transplantation with Portal-Enteric Drainage, Transplantation, vol.79, issue.9, pp.1137-1179, 2005.
DOI : 10.1097/01.TP.0000157279.39761.CC

B. Barrou, M. Bitker, and A. Grimaldi, Transplantation pancréatique: indications, résultats et perspectives, pp.10-366, 2004.
DOI : 10.1016/j.emcend.2003.10.002

D. Sutherland, F. Goetz, and R. Sibley, Recurrence of Disease in Pancreas Transplants, Diabetes, vol.38, issue.Supplement_1, pp.85-87, 1989.
DOI : 10.2337/diab.38.1.S85

C. Thivolet, S. Abou-amara, and X. Martin, SEROLOGICAL MARKERS OF RECURRENT BETA CELL DESTRUCTION IN DIABETIC PATIENTS UNDERGOING PANCREATIC TRANSPLANTATION, Transplantation, vol.69, issue.1, pp.99-103, 2000.
DOI : 10.1097/00007890-200001150-00018

D. Cantarovich and F. Vistoli, Minimization protocols in pancreas transplantation, Transplant International, vol.8, issue.suppl 11, pp.61-68, 2009.
DOI : 10.1111/j.1600-6143.2007.02053.x

A. Shapiro, J. Lakey, E. Ryan, G. Korbutt, E. Toth et al., Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen, New England Journal of Medicine, vol.343, issue.4, pp.230-238, 2000.
DOI : 10.1056/NEJM200007273430401

A. Shapiro, C. Ricordi, and B. Hering, International Trial of the Edmonton Protocol for Islet Transplantation, New England Journal of Medicine, vol.355, issue.13, pp.1318-1330, 2006.
DOI : 10.1056/NEJMoa061267

R. Alejandro, F. Barton, B. Hering, and S. Wease, Collaborative Islet Transplant Registry Investigators, Update from the Collaborative Islet Transplant Registry. Transplantation, vol.86, issue.12, pp.1783-1788, 2008.

R. Lehmann, G. Spinas, W. Moritz, and M. Weber, Has Time Come for New Goals in Human Islet Transplantation?, American Journal of Transplantation, vol.8, issue.6, p.1096, 2008.
DOI : 10.1111/j.1600-6143.2007.02060.x

R. Robertson, K. Lanz, and D. Sutherland, Prevention of Diabetes for up to 13 Years by Autoislet Transplantation After Pancreatectomy for Chronic Pancreatitis, Diabetes, vol.50, issue.1, pp.47-50, 2001.
DOI : 10.2337/diabetes.50.1.47

R. Gruessner, D. Sutherland, and R. Kandaswamy, Over 500 Solitary Pancreas Transplants in Nonuremic Patients with Brittle Diabetes Mellitus, Transplantation, vol.85, issue.1, pp.42-47, 2008.
DOI : 10.1097/01.tp.0000296820.46978.3f

R. Lehmann, M. Weber, and P. Betihold, Successful Simultaneous Islet-Kidney Transplantation using a Steroid-free Immunosuppression: Two-Year Follow-up, American Journal of Transplantation, vol.3, issue.1, pp.1117-1123, 2004.
DOI : 10.3727/000000002783985369

C. Toso, R. Baertschiger, and P. Morel, Sequential Kidney/Islet Transplantation: Efficacy and Safety Assessment of a Steroid-Free Immunosuppression Protocol, American Journal of Transplantation, vol.234, issue.Supp 11, pp.1049-1058, 2006.
DOI : 10.1097/01.TP.0000133539.74599.0B

URL : https://hal.archives-ouvertes.fr/hal-00389400

C. Ricordi, P. Lacy, and E. Finke, Automated Method for Isolation of Human Pancreatic Islets, Diabetes, vol.37, issue.4, pp.413-420, 1988.
DOI : 10.2337/diab.37.4.413

P. Bucher, Z. Mathe, and P. Morel, Assessment of a Novel Two-Component Enzyme Preparation for Human Islet Isolation and Transplantation, Transplantation, vol.79, issue.1, pp.91-97, 2005.
DOI : 10.1097/01.TP.0000147344.73915.C8

C. Ricordi, Islet isolation assessment in man and large animals, Acta Diabetologica Latina, vol.164, issue.Suppl. 1, pp.185-195, 1990.
DOI : 10.2337/diab.29.1.S74

A. Shapiro, PORTAL VEIN THROMBOSIS AFTER TRANSPLANTATION OF PARTIALLY PURIFIED PANCREATIC ISLETS IN A COMBINED HUMAN LIVER/ISLET ALLOGRAFT, Transplantation, vol.59, issue.7, pp.1-060, 1995.
DOI : 10.1097/00007890-199504150-00027

M. Kempf, A. Andres, and P. Morel, GRAGIL group. Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation. Transplantation, pp.1200-1205, 2005.

P. Benhamou, J. Oberholzer, and C. Toso, Human islet transplantation network for the treatment of Type l diabetes: first data from the Swiss- French GRAGIL consortium (1999-2000) Groupe de Recherche Rhin Rhône Alpes Genève pour la transplantation d'Ilots de Langerhans, Diabetologia, vol.44, issue.7, pp.859-64, 2001.

T. Lundgren, . Korsgren-0, and A. Foss, THE NORDIC NETWORK FOR CLINICAL ISLET TRANSPLANTATION - ISLET AFTER KIDNEY (IAK) - RESULTS AND EXPERIENCES FROM THE FIRST 44 TRANSPLANTATIONS., Transplantation, vol.78, issue.2, p.178, 2004.
DOI : 10.1097/00007890-200407271-00466

E. Ryan, P. Y. Bw, and P. Senior, ??-Score: An assessment of ??-cell function after islet transplantation, Diabetes Care, vol.28, issue.2, pp.343-347, 2005.
DOI : 10.2337/diacare.28.2.343

M. Rickels, A. Naji, and K. Teff, Acute Insulin Responses to Glucose and Arginine as Predictors of ??-Cell Secretory Capacity in Human Islet Transplantation, Transplantation, vol.84, issue.10, pp.1357-1360, 2007.
DOI : 10.1097/01.tp.0000287595.16442.a7

D. Baidal, R. Faradji, and S. Messinger, Early Metabolic Markers of Islet Allograft Dysfunction, Transplantation, vol.87, issue.5, pp.689-697, 2009.
DOI : 10.1097/TP.0b013e318195c249

M. Vantyghem, J. Kerr-conte, and L. Arnalsteen, Primary Graft Function, Metabolic Control, and Graft Survival After Islet Transplantation, Diabetes Care, vol.32, issue.8, pp.1473-1478, 2009.
DOI : 10.2337/dc08-1685

URL : http://care.diabetesjournals.org/content/diacare/32/8/1473.full.pdf

R. Cardani, A. Pileggi, and C. Ricordi, Allosensitization of Islet Allograft Recipients, Transplantation, vol.84, issue.11, pp.1413-1427, 2007.
DOI : 10.1097/01.tp.0000290388.70019.6e

P. Campbell, P. Senior, and A. Salam, High Risk of Sensitization After Failed Islet Transplantation, American Journal of Transplantation, vol.174, issue.10, pp.2311-2317, 2007.
DOI : 10.4049/jimmunol.174.1.542

E. Bosi, S. Braghi, and P. Maffi, Autoantibody Response to Islet Transplantation in Type 1 Diabetes, Diabetes, vol.50, issue.11, pp.2464-2471, 2001.
DOI : 10.2337/diabetes.50.11.2464

V. A. Huurman, R. Hilbrands, and G. Pinkse, Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation, PLoS ONE, vol.2, issue.6, p.2435, 2008.
DOI : 10.1371/journal.pone.0002435.s004

T. Froud, R. Faradji, and A. Pileggi, The Use of Exenatide in Islet Transplant Recipients with Chronic Allograft Dysfunction: Safety, Efficacy, and Metabolic Effects, Transplantation, vol.86, issue.1, pp.36-45, 2008.
DOI : 10.1097/TP.0b013e31817c4ab3

R. Faradji, T. Tharavanij, and S. Messinger, Long-Term Insulin Independence and Improvement in Insulin Secretion After Supplemental Islet Infusion Under Exenatide and Etanercept, Transplantation, vol.86, issue.12, pp.1658-1665, 2008.
DOI : 10.1097/TP.0b013e31818fe448

C. Ricordi, Lilly Lecture 2002: Islet Transplantation: A Brave New World, Diabetes, vol.52, issue.7, pp.1595-1603, 2003.
DOI : 10.2337/diabetes.52.7.1595

A. Pileggi, L. Cobianchi, and L. Inverardi, Overcoming the Challenges Now Limiting Islet Transplantation: A Sequential, Integrated Approach, Annals of the New York Academy of Sciences, vol.53, issue.1, pp.383-398, 2006.
DOI : 10.1097/01.TP.0000112436.26473.A2

M. Hafiz, R. Faradji, and T. Froud, Immunosuppression and Procedure-Related Complications in 26 Patients with Type 1 Diabetes Mellitus Receiving Allogeneic Islet Cell Transplantation, Transplantation, vol.80, issue.12, pp.1718-1728, 2005.
DOI : 10.1097/01.tp.0000187881.97068.77

P. Senior, M. Zeman, and P. Y. Bw, Changes in Renal Function after Clinical Islet Transplantation: Four-Year Observational Study, American Journal of Transplantation, vol.28, issue.1, pp.91-98, 2007.
DOI : 10.1002/lt.20017

P. Maffi, F. Bertuzzi, D. Taddeo, and F. , Kidney Function After Islet Transplant Alone in Type 1 Diabetes: Impact of immunosuppressive therapy on progression of diabetic nephropathy, Diabetes Care, vol.30, issue.5, pp.1150-1155, 2007.
DOI : 10.2337/dc06-1794

P. Cure, A. Pileggi, and T. Froud, Improved Metabolic Control and Quality of Life in Seven Patients With Type 1 Diabetes Following Islet After Kidney Transplantation, Transplantation, vol.85, issue.6, pp.801-812, 2008.
DOI : 10.1097/TP.0b013e318166a27b

G. Warnock, D. Thompson, and R. Meloche, A Multi-Year Analysis of Islet Transplantation Compared With Intensive Medical Therapy on Progression of Complications in Type 1 Diabetes, Transplantation, vol.86, issue.12, pp.1762-1766, 2008.
DOI : 10.1097/TP.0b013e318190b052

A. Hyder, C. Laue, and J. Schrezenmeir, Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories, Toxicology in Vitro, vol.19, issue.4, pp.541-546, 2005.
DOI : 10.1016/j.tiv.2005.01.005

S. Nanji and A. Shapiro, Islet Transplantation in Patients with Diabetes Mellitus, BioDrugs, vol.9, issue.2, pp.315-347, 2004.
DOI : 10.2165/00063030-200418050-00004

A. Ojo, H. Meier-kriesche, and J. Hanson, THE IMPACT OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ON LONG-TERM PATIENT SURVIVAL1, Transplantation, vol.71, issue.1, pp.82-90, 2001.
DOI : 10.1097/00007890-200101150-00014

P. Gerber, V. Pavlicek, and N. Demartines, Simultaneous islet???kidney vs pancreas???kidney transplantation in type 1 diabetes mellitus: a 5??year single centre follow-up, Diabetologia, vol.49, issue.Suppl 1, pp.110-119, 2008.
DOI : 10.7326/0003-4819-130-6-199903160-00002

L. Kessler, R. Passemard, and J. Oberholzer, Reduction of Blood Glucose Variability in Type 1 Diabetic Patients Treated By Pancreatic Islet Transplantation: Interest of continuous glucose monitoring, Diabetes Care, vol.25, issue.12, pp.2256-62, 2002.
DOI : 10.2337/diacare.25.12.2256

R. Bilous, S. Mauer, and D. Sutherland, The Effects of Pancreas Transplantation on the Glomerular Structure of Renal Allografts in Patients with Insulin-Dependent Diabetes, New England Journal of Medicine, vol.321, issue.2, pp.80-85, 1989.
DOI : 10.1056/NEJM198907133210204

P. Fioretto, M. Steffes, and D. Sutherland, Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation, New England Journal of Medicine, vol.339, issue.2, pp.69-75, 1998.
DOI : 10.1056/NEJM199807093390202

A. Israni, H. Feldman, and K. Propelt, Impact of Simultaneous Kidney-Pancreas Transplant and Timing of Transplant on Kidney Allograft Survival, American Journal of Transplantation, vol.154, issue.38, pp.374-382, 2005.
DOI : 10.1093/ndt/18.1.172

F. Kleinclauss, M. Fauda, and S. De, Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function, Clinical Transplantation, vol.70, issue.Suppl 2, 2009.
DOI : 10.7326/0003-4819-130-6-199903160-00002

URL : https://hal.archives-ouvertes.fr/inserm-00484545

J. Scalea, C. Butler, and R. Munivenkatappa, Pancreas Transplant Alone as an Independent Risk Factor for the Development of Renal Failure: A Retrospective Study, Transplantation, vol.86, issue.12, pp.1789-94, 2008.
DOI : 10.1097/TP.0b013e3181913fbf

. Fiorina, Natural History of Kidney Graft Survival, Hypertrophy, and Vascular Function in End-Stage Renal Disease Type 1 Diabetic Kidney-Transplanted Patients: Beneficial impact of pancreas and successful islet cotransplantation, Diabetes Care, vol.28, issue.6, pp.1303-1313, 2005.
DOI : 10.2337/diacare.28.6.1303

R. Ramsay, F. Goetz, and D. Sutherland, Progression of Diabetic Retinopathy after Pancreas Transplantation for Insulin-Dependent Diabetes Mellitus, New England Journal of Medicine, vol.318, issue.4, pp.208-214, 1988.
DOI : 10.1056/NEJM198801283180403

D. Carro, U. Fiorina, P. Amadio, and S. , Evaluation of Polyneuropathy Markers in Type 1 Diabetic Kidney Transplant Patients and Effects of Islet Transplantation: Neurophysiological and skin biopsy longitudinal analysis, Diabetes Care, vol.30, issue.12, pp.3063-3069, 2007.
DOI : 10.2337/dc07-0206

L. Luzi, G. Perseghin, and M. Brendel, Metabolic Effects of Restoring Partial ??-Cell Function After Islet Allotransplantation in Type 1 Diabetic Patients, Diabetes, vol.50, issue.2, pp.277-282, 2001.
DOI : 10.2337/diabetes.50.2.277

D. Sutherland, R. Gruessner, and D. Dunn, Lessons Learned From More Than 1,000 Pancreas Transplants at a Single Institution, Annals of Surgery, vol.233, issue.4, pp.463-501, 2001.
DOI : 10.1097/00000658-200104000-00003

C. Gross, C. Limwattananon, and B. Matthees, Quality of life after pancreas transplantation: a review, Clin Transplant, vol.12, pp.351-61, 1998.

E. Adang, G. L. Engel, V. Hoof, and J. , COMPARISON BEFORE AND AFTER TRANSPLANTATION OF PANCREAS-KIDNEY AND PANCREAS-KIDNEY WITH LOSS OF PANCREAS-A PROSPECTIVE CONTROLLED QUALITY OF LIFE STUDY1,2, Transplantation, vol.62, issue.6, pp.754-758, 1996.
DOI : 10.1097/00007890-199609270-00009

T. Tharavanij, A. Betancourt, S. Messinger, and P. Cure, Improved long-term health-related quality of life after islet transplantation.Transplantation, Nov, vol.1586, issue.9, pp.1161-1168, 2008.

P. Cure, A. Pileggi, T. Froud, S. Messinger, R. Faradji et al., Improved metabolic control and quality of lite in seven patients with type 1 diabetes following islet after kidney transplantation.Transplantation, pp.801-813, 2008.

R. Poggioli, R. Faradji, G. Ponte, A. Betancourt, S. Messinger et al., Quality of Life After Islet Transplantation, American Journal of Transplantation, vol.26, issue.2, pp.371-378, 2006.
DOI : 10.1097/01.TP.0000160816.21799.F5

N. Barshes, J. Vanatta, A. Mote, T. Lee, A. Schock et al., Health-Related Quality of Life after Pancreatic Islet Transplantation: A Longitudinal Study, Transplantation, vol.79, issue.12, pp.1-727, 2005.
DOI : 10.1097/01.TP.0000160816.21799.F5

C. Toso, A. Shapiro, S. Bowker, P. Dinyari, P. Y. et al., Quality of Life After Islet Transplant: Impact of the Number of Islet Infusions and Metabolic Outcome, Transplantation, vol.84, issue.5, pp.664-670, 2007.
DOI : 10.1097/01.tp.0000280550.01028.89

. Debat-y-1, M. Baudrant, and P. Benhamou, ??valuation de la qualit?? de vie en ??ducation th??rapeutique du patient diab??tique??: int??r??ts et limites des ??chelles de mesure standardis??es, Médecine des maladies Métaboliques, pp.2-291, 2008.
DOI : 10.1016/S1957-2557(08)71675-4

A. Garrat, L. Scmidt, and R. Fitzpatrick, Patient-assessed health outcome measures for diabetes: a structured review, Diabetic Medicine, vol.10, issue.14, pp.1-11, 2002.
DOI : 10.1111/j.1464-5491.1993.tb00134.x

. Speight-l, M. Reaney, and D. Barnard, Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes, Diabetic Medicine, vol.4, issue.4, pp.315-327, 2009.
DOI : 10.1097/00006842-199701000-00004

E. Renard, V. Vague, and H. Hanaire, Validation psychomtrique d'une version française du questionnaire d' évaluation de la qualité de vie du diabétique élaboré par le DCCT research group (DQOL) Pancreatic islet transplantation: the radiographic approach, Diabetes Metab Transplantation, vol.2576, pp.22-199, 1999.

L. Kessler, C. Lucescu, and M. Pinget, Tacrolimus-Associated Optic Neuropathy after Pancreatic Islet Transplantation using a Sirolimus/Tacrolimus Immunosuppressive Regimen Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy, Transplantation Transplantation, vol.8185, pp.1400-1405, 2006.

P. Benhamou, L. Milliat-guittard, and A. Wojtusciszn, Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials, Diabetic Medicine, vol.27, issue.6, pp.617-621, 2009.
DOI : 10.1111/j.1464-5491.2009.02731.x

URL : https://hal.archives-ouvertes.fr/hal-00438784

. Voici-une-liste, Lisez attentivement chacune des questions suivantes Répondez en indiquant la fréquence avec laquelle chaque situatioll se produit. Ne cochez qu'ulle seule case pal' question. Il Il'y a pas de bonnes ou de mauvaises répollses